Jefferies Group's CORT Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 58,081 shares of Corcept Therapeutics Incorporated (CORT) worth $2.02 M, representing 0.01% of the portfolio. First purchased in 2024-Q1, this short-term holding has been held for 3 quarters.
Based on 13F filings, Jefferies Group has maintained this position in CORT for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 58,081 shares. Largest reduction occurred in Q2 2024, reducing 103,553 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Corcept Therapeutics Incorporated (CORT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Corcept Therapeutics Incorporated (CORT) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +58,081 | New Buy | 58,081 | $34.80 |
| Q2 2024 | -103,553 | Sold Out | 0 | $0.00 |
| Q1 2024 | +103,553 | New Buy | 103,553 | $25.19 |
Jefferies Group's Corcept Therapeutics Incorporated Investment FAQs
Jefferies Group first purchased Corcept Therapeutics Incorporated (CORT) in Q1 2024, acquiring 103,553 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Corcept Therapeutics Incorporated (CORT) for 3 quarters since Q1 2024.
Jefferies Group's largest addition to Corcept Therapeutics Incorporated (CORT) was in Q1 2024, adding 103,553 shares worth $2.61 M.
According to the latest 13F filing for Q4 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 58,081 shares of Corcept Therapeutics Incorporated (CORT), valued at approximately $2.02 M.
As of the Q4 2025 filing, Corcept Therapeutics Incorporated (CORT) represents approximately 0.01% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Corcept Therapeutics Incorporated (CORT) was 103,553 shares, as reported at the end of Q1 2024.